Search Medical Condition
Please enter condition
Please choose location from dropdown
 

Small Cell Lung Cancer Clinical Trials

A listing of Small Cell Lung Cancer medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (1130) clinical trials

People with Non-squamous non-small cell lung cancer (NSCLC) or cisplatin-eligible urothelial cancer are asked to participate in a research study being conducted by Montefiore Medical Center.

Phase N/A

A research study is evaluating an investigational oral medication for non-small cell lung cancer (NSCLC). This research study may be an option if you: • Are at least 18 years of age • Have been diagnosed with stage IIIB or IV metastatic NSCLC • Have fully recovered from any previous ...

Phase N/A

People with Advanced or Metastatic Nonsmall Cell Lung Cancer are asked to participate in a research study being conducted by Montefiore Medical Center.

Phase N/A

This is a multicenter, open-label, multi-arm Phase 2 study to evaluate the efficacy and safety of single agent niraparib in patients with locally advanced and metastatic sqNSCLC and of the combination of niraparib and pembrolizumab in locally advanced and metastatic NSCLC (all histologies) patients. 

Phase N/A

People with non-small cell lung cancer are asked to participate in a research study being conducted by White Plains Hospital.

Phase N/A

People with suspicion of lung cancer who are scheduled for a biopsy/other diagnostic procedure are asked to participate in a research study being conducted by Long Island Jewish Medical Center.

Phase N/A

People with non-small cell lung cancer are asked to participate in a research study being conducted by White Plains Hospital.

Phase N/A

SABR-ATAC: A Trial of TGF-beta Inhibition and Stereotactic Ablative Radiotherapy for Early Stage Non-small Cell Lung Cancer

PRIMARY OBJECTIVES: I. Evaluate the safe dose of fresolimumab in combination with stereotactic ablative radiotherapy (SABR) in patients. (Phase I) II. Evaluate the rate of radiation induced pulmonary fibrosis after SABR plus fresolimumab. (Phase II) SECONDARY OBJECTIVES: I. Evaluate potential adverse events in patients receiving fresolimumab plus SABR. (Phase I) ...

Phase

FLARE RT for Patients With Stage IIB-IIIB Non-small Cell Lung Cancer: Personalizing Radiation Therapy Using PET/CT and SPECT/CT Imaging

PRIMARY OBJECTIVE: I. To test the superiority of 2 year (yr) overall survival (OS) in the functional lung avoidance and response-adaptive dose escalation (FLARE) radiation therapy (RT) patient cohort over the 60 gray (Gy) cohort of Radiation Therapy Oncology Group (RTOG) 0617 (57% 2yr OS) for historical control. SECONDARY OBJECTIVE: ...

Phase

Tisotumab Vedotin Continued Treatment in Patients With Solid Tumors.

This is an open-label, multicenter trial to collect long-term safety and efficacy data and to provide ongoing access to tisotumab vedotin for patients with solid tumors who have completed a tisotumab vedotin base trial.

Phase